Medroxyprogesterone acetate (MPA) is a synthetic progestin hormone administered to mares off-label in an attempt to suppress behavioral estrus. However, a controlled research study found that MPA was not effective at suppression of behavioral estrus.1 Many veterinarians believe MPA modifies behavior by producing a calming effect in the horse and does not have a therapeutic benefit that goes beyond this behavior modification. Therefore, the AAEP recommends that MPA should not be administered to horses in competition.
1. Gee EK, C DeLuca, JL Stylski, PM McCue. Efficacy of medroxyprogesterone acetate in suppression of estrus in cycling mares. J Equine Vet Sci 2009;29:140-145.
Reviewed by the AAEP board of directors in 2025.
Related Resources
Learn to Recognize Your Horse’s Dental Problems
It is important to catch dental problems early. If a horse starts…
Clinical Guidelines for Veterinarians Treating the Performance Horse
Performance horses compete in a wide range of athletic activities and a…
AAEP Position on Therapeutic Medication for the Competition Horse
The AAEP policy on medication in the competition horse is driven by…